Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
2013197 citationsJournal Articlebronze Open Access
Field-Weighted Citation Impact: 15.11
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study | Researchclopedia